Jul 15, 2026 04:09AM
Jun 2, 2026 06:53AM
Jun 1, 2026 04:26PM
Jun 1, 2026 11:07AM
May 15, 2026 09:00AM
May 5, 2026 04:15PM
Apr 13, 2026 03:27AM Jefferies Starts Veracyte, Inc (VCYT) at Buy
Apr 1, 2026 05:38AM
Mar 16, 2026 04:15PM
Mar 5, 2026 05:35PM
Feb 26, 2026 07:14AM
Feb 25, 2026 04:23PM
Jan 12, 2026 09:52AM
Jan 12, 2026 05:59AM Needham Reiterates Buy Rating on Veracyte (VCYT)
Jan 12, 2026 04:04AM
Nov 5, 2025 05:46AM
Nov 5, 2025 01:59AM
Nov 4, 2025 04:21PM
Oct 20, 2025 05:11AM
Oct 16, 2025 04:09PM
Sep 29, 2025 04:36AM Veracyte biomarker predicts hormone therapy benefit in prostate cancer
Sep 24, 2025 09:03AM
Aug 27, 2025 11:25AM
Aug 26, 2025 08:35AM
Aug 8, 2025 02:49PM
Aug 7, 2025 05:36AM
Aug 6, 2025 04:12PM
Jul 24, 2025 05:20PM Veracyte (VCYT) added to S&P 600
May 21, 2025 12:48PM
May 8, 2025 06:13AM
May 7, 2025 04:15PM
Apr 25, 2025 07:00AM
Apr 21, 2025 04:07PM
Apr 9, 2025 07:20AM
Mar 20, 2025 09:44AM Craig-Hallum Starts Veracyte, Inc (VCYT) at Buy
Feb 25, 2025 06:11AM
Feb 24, 2025 04:10PM
Jan 29, 2025 07:58AM
Dec 9, 2024 05:55AM
Dec 5, 2024 04:15AM
Nov 15, 2024 06:02AM
Nov 7, 2024 07:39AM Veracyte, Inc (VCYT) PT Raised to $44 at Needham
Nov 6, 2024 04:15PM
Oct 16, 2024 03:51AM
Sep 30, 2024 07:34AM
Sep 4, 2024 04:05PM
Aug 28, 2024 05:43AM
Aug 7, 2024 07:40AM
Aug 6, 2024 04:20PM Veracyte (VCYT) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY24 Revenue Guidance

418,483 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All